Scientific posters

Over the past years, we have built the expertise and infrastructure required to differentiate, manufacture and characterize iPSC-derived cell models for drug discovery and cell therapy. Many of our developments and innovations have been presented during events. On this page, you will find a selection of scientific posters, visually representing data in cardiac or neural stem cell research.

Contact us!

We're here to listen to your project plans, questions and challenges, and to co-develop a solution that fits your specifications. Please leave your details and message in the form below and we will get back to you as soon as possible.

Cardiac

Simultaneous Measurement of Contractility, Electrophysiology, and Troponin I Secretion to Determine Cardiotoxicity in hiPSC-Derived Cardiomyocytes
High Throughput assessment of cardiotoxicity by Calcium-Flux using hiPSC-derived Cardiomyocytes
Voltage and calcium sensitive dye recording from hiPSC-derived cardiomyocytes using the Hamamatsu FDSS plate reader (for (96 well) cardiac safety assessment/assay) to assess drug-induced cardiac liabilities – In collaboration with Servier
High throughput assessment of cardiotoxicity in hiPSC-derived cardiomyocytes
Assessment of electrophysiology, contractility and viability effects of three UCB compounds on human induced pluripotent stem cell-derived (hiPSC) cardiomyocytes using the Real Time Cell Analyzer (RTCA) CardioECR platform – In collaboration with UCB Biopharma
Application of human-induced pluripotent stem cell-derived cardiomyocytes in high-throughput screening assays for drug safety and efficacy testing
High-throughput assessment of drug effects on calcium transients in human induced pluripotent stem cell (hiPSC) derived cardiomyocytes
Multiparametric Assessment of Cardiotoxicity of Chemotherapeutic Drugs in Human Induced Pluripotent Stem Cell (hiPSC)-Derived Cardiomyocytes
Studying Inotropic Compound Effects in Relatively Mature Human iPSC-derived Cardiomyocytes using 2D and 3D Models
Application of Human-Induced Pluripotent Stem Cell Derived Cardiomyocytes in High-Throughput Screening Assays for Drug Safety and Efficacy Testing
Assessment of in vitro compound-induced pro-arrhythmia in Pluricyte® Cardiomyocytes
Multiparametric assessment of the effects of TKIs on the (electro)physiology of Pluricyte® Cardiomyocytes
Characterization of electrical and mechanical functions of Pluricyte® Cardiomyocytes using CellOPTIQ® – In collaboration with Clyde Biosciences
Assessment of compound effects on electrophysiology of Pluricyte® Cardiomyocytes using patch clamp and MEA – In collaboration with PhysioStim
Human pluripotent stem cell-derived cardiomyocytes generated with a well-defined cardiac differentiation media kit for use in basic and applied research
In vitro pro-arrhyhtmia detection in Pluricyte^® Cardiomyocytes using multiple MEA assays
MEA based electrophysiological characterization of Pluricyte^® Cardiomyocytes
Using Pluricyte^® Cardiomyocytes in the xCELLigence CardioECR platform

Neural

Establishment of relevant human iPSC-derived models in the context of neurobiology and neurodegeneration
Optimization of a Human Stem Cell-Derived Neuron/Astrocyte Co-Culture System for Seizure Liability Assessment Using Microelectrode Arrays
High-Content Assay for Morphological Characterization of Neuronal Development in 3D Matrix Using Human iPSC-Derived Neuronal Cultures
Neurotransmitter Screening via Dynamic Calcium Flux and MEA-based Seizure Liability Assessment in Human iPS Neurons

Questions?

Would you like to receive more information?